Cargando…
The Effect of Hyaluronic Acid and Chondroitin Sulphate-Based Medical Device Combined with Acid Suppression in the Treatment of Atypical Symptoms in Gastroesophageal Reflux Disease
Extraesophageal reflux symptoms are increasingly common in the Western population and their clinical management is still controversial. Although therapy with proton-pump inhibitors (PPIs) represents the gold standard, to date, many patients are refractory to this treatment. The aim of this study was...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000081/ https://www.ncbi.nlm.nih.gov/pubmed/35407497 http://dx.doi.org/10.3390/jcm11071890 |
_version_ | 1784685346468921344 |
---|---|
author | Pellegatta, Gaia Mangiavillano, Benedetto Semeraro, Rossella Auriemma, Francesco Carlani, Elisa Fugazza, Alessandro Vespa, Edoardo Repici, Alessandro |
author_facet | Pellegatta, Gaia Mangiavillano, Benedetto Semeraro, Rossella Auriemma, Francesco Carlani, Elisa Fugazza, Alessandro Vespa, Edoardo Repici, Alessandro |
author_sort | Pellegatta, Gaia |
collection | PubMed |
description | Extraesophageal reflux symptoms are increasingly common in the Western population and their clinical management is still controversial. Although therapy with proton-pump inhibitors (PPIs) represents the gold standard, to date, many patients are refractory to this treatment. The aim of this study was to evaluate, in patients with a recent diagnosis of GERD experiencing extraesophageal symptoms, the efficacy and safety of a 6-week treatment with PPI acid suppression in combination with Gerdoff(®) (a hyaluronic acid and chondroitin sulphate-based medical device) compared to PPI monotherapy. The trial verified the reduction in symptom frequency and severity by evaluating the proportion of Responders and Non-Responder patients after 6 weeks of treatment, compared to baseline. The effects of Gerdoff(®) + PPI treatment on extraesophageal symptoms were also evaluated after a 12-week follow up only in Responder patients. The analysis of the change in total Reflux Symptoms Index (RSI) score from baseline to the other time points showed that the extent of the decrease from baseline was higher in the Gerdoff(®) + PPI group than in the PPI group at any time point. However, the comparison between groups did not show statistically significant differences at any time point. A statistically significant difference, in favor of the Gerdoff(®) + PPI group, was observed for individual RSI items. Even if the trial showed some limitations, this is the first published study on the efficacy of a medical device containing hyaluronic acid and chondroitin sulphate with antacid in the treatment of extraesophageal reflux symptoms. |
format | Online Article Text |
id | pubmed-9000081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90000812022-04-12 The Effect of Hyaluronic Acid and Chondroitin Sulphate-Based Medical Device Combined with Acid Suppression in the Treatment of Atypical Symptoms in Gastroesophageal Reflux Disease Pellegatta, Gaia Mangiavillano, Benedetto Semeraro, Rossella Auriemma, Francesco Carlani, Elisa Fugazza, Alessandro Vespa, Edoardo Repici, Alessandro J Clin Med Article Extraesophageal reflux symptoms are increasingly common in the Western population and their clinical management is still controversial. Although therapy with proton-pump inhibitors (PPIs) represents the gold standard, to date, many patients are refractory to this treatment. The aim of this study was to evaluate, in patients with a recent diagnosis of GERD experiencing extraesophageal symptoms, the efficacy and safety of a 6-week treatment with PPI acid suppression in combination with Gerdoff(®) (a hyaluronic acid and chondroitin sulphate-based medical device) compared to PPI monotherapy. The trial verified the reduction in symptom frequency and severity by evaluating the proportion of Responders and Non-Responder patients after 6 weeks of treatment, compared to baseline. The effects of Gerdoff(®) + PPI treatment on extraesophageal symptoms were also evaluated after a 12-week follow up only in Responder patients. The analysis of the change in total Reflux Symptoms Index (RSI) score from baseline to the other time points showed that the extent of the decrease from baseline was higher in the Gerdoff(®) + PPI group than in the PPI group at any time point. However, the comparison between groups did not show statistically significant differences at any time point. A statistically significant difference, in favor of the Gerdoff(®) + PPI group, was observed for individual RSI items. Even if the trial showed some limitations, this is the first published study on the efficacy of a medical device containing hyaluronic acid and chondroitin sulphate with antacid in the treatment of extraesophageal reflux symptoms. MDPI 2022-03-29 /pmc/articles/PMC9000081/ /pubmed/35407497 http://dx.doi.org/10.3390/jcm11071890 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pellegatta, Gaia Mangiavillano, Benedetto Semeraro, Rossella Auriemma, Francesco Carlani, Elisa Fugazza, Alessandro Vespa, Edoardo Repici, Alessandro The Effect of Hyaluronic Acid and Chondroitin Sulphate-Based Medical Device Combined with Acid Suppression in the Treatment of Atypical Symptoms in Gastroesophageal Reflux Disease |
title | The Effect of Hyaluronic Acid and Chondroitin Sulphate-Based Medical Device Combined with Acid Suppression in the Treatment of Atypical Symptoms in Gastroesophageal Reflux Disease |
title_full | The Effect of Hyaluronic Acid and Chondroitin Sulphate-Based Medical Device Combined with Acid Suppression in the Treatment of Atypical Symptoms in Gastroesophageal Reflux Disease |
title_fullStr | The Effect of Hyaluronic Acid and Chondroitin Sulphate-Based Medical Device Combined with Acid Suppression in the Treatment of Atypical Symptoms in Gastroesophageal Reflux Disease |
title_full_unstemmed | The Effect of Hyaluronic Acid and Chondroitin Sulphate-Based Medical Device Combined with Acid Suppression in the Treatment of Atypical Symptoms in Gastroesophageal Reflux Disease |
title_short | The Effect of Hyaluronic Acid and Chondroitin Sulphate-Based Medical Device Combined with Acid Suppression in the Treatment of Atypical Symptoms in Gastroesophageal Reflux Disease |
title_sort | effect of hyaluronic acid and chondroitin sulphate-based medical device combined with acid suppression in the treatment of atypical symptoms in gastroesophageal reflux disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000081/ https://www.ncbi.nlm.nih.gov/pubmed/35407497 http://dx.doi.org/10.3390/jcm11071890 |
work_keys_str_mv | AT pellegattagaia theeffectofhyaluronicacidandchondroitinsulphatebasedmedicaldevicecombinedwithacidsuppressioninthetreatmentofatypicalsymptomsingastroesophagealrefluxdisease AT mangiavillanobenedetto theeffectofhyaluronicacidandchondroitinsulphatebasedmedicaldevicecombinedwithacidsuppressioninthetreatmentofatypicalsymptomsingastroesophagealrefluxdisease AT semerarorossella theeffectofhyaluronicacidandchondroitinsulphatebasedmedicaldevicecombinedwithacidsuppressioninthetreatmentofatypicalsymptomsingastroesophagealrefluxdisease AT auriemmafrancesco theeffectofhyaluronicacidandchondroitinsulphatebasedmedicaldevicecombinedwithacidsuppressioninthetreatmentofatypicalsymptomsingastroesophagealrefluxdisease AT carlanielisa theeffectofhyaluronicacidandchondroitinsulphatebasedmedicaldevicecombinedwithacidsuppressioninthetreatmentofatypicalsymptomsingastroesophagealrefluxdisease AT fugazzaalessandro theeffectofhyaluronicacidandchondroitinsulphatebasedmedicaldevicecombinedwithacidsuppressioninthetreatmentofatypicalsymptomsingastroesophagealrefluxdisease AT vespaedoardo theeffectofhyaluronicacidandchondroitinsulphatebasedmedicaldevicecombinedwithacidsuppressioninthetreatmentofatypicalsymptomsingastroesophagealrefluxdisease AT repicialessandro theeffectofhyaluronicacidandchondroitinsulphatebasedmedicaldevicecombinedwithacidsuppressioninthetreatmentofatypicalsymptomsingastroesophagealrefluxdisease AT pellegattagaia effectofhyaluronicacidandchondroitinsulphatebasedmedicaldevicecombinedwithacidsuppressioninthetreatmentofatypicalsymptomsingastroesophagealrefluxdisease AT mangiavillanobenedetto effectofhyaluronicacidandchondroitinsulphatebasedmedicaldevicecombinedwithacidsuppressioninthetreatmentofatypicalsymptomsingastroesophagealrefluxdisease AT semerarorossella effectofhyaluronicacidandchondroitinsulphatebasedmedicaldevicecombinedwithacidsuppressioninthetreatmentofatypicalsymptomsingastroesophagealrefluxdisease AT auriemmafrancesco effectofhyaluronicacidandchondroitinsulphatebasedmedicaldevicecombinedwithacidsuppressioninthetreatmentofatypicalsymptomsingastroesophagealrefluxdisease AT carlanielisa effectofhyaluronicacidandchondroitinsulphatebasedmedicaldevicecombinedwithacidsuppressioninthetreatmentofatypicalsymptomsingastroesophagealrefluxdisease AT fugazzaalessandro effectofhyaluronicacidandchondroitinsulphatebasedmedicaldevicecombinedwithacidsuppressioninthetreatmentofatypicalsymptomsingastroesophagealrefluxdisease AT vespaedoardo effectofhyaluronicacidandchondroitinsulphatebasedmedicaldevicecombinedwithacidsuppressioninthetreatmentofatypicalsymptomsingastroesophagealrefluxdisease AT repicialessandro effectofhyaluronicacidandchondroitinsulphatebasedmedicaldevicecombinedwithacidsuppressioninthetreatmentofatypicalsymptomsingastroesophagealrefluxdisease |